Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) EVP Kevin M. Ban sold 10,303 shares of the stock in a transaction that occurred on Friday, November 18th. The shares were sold at an average price of $40.19, for a total value of $414,077.57. Following the transaction, the executive vice president now owns 27,916 shares in the company, valued at approximately $1,121,944.04. The sale was disclosed in a document filed with the SEC, which is available through this link.
Walgreens Boots Alliance Stock Down 0.1 %
Shares of WBA opened at $41.76 on Thursday. Walgreens Boots Alliance, Inc. has a 52-week low of $30.39 and a 52-week high of $55.00. The company has a market capitalization of $36.11 billion, a PE ratio of 8.35, a price-to-earnings-growth ratio of 1.86 and a beta of 0.71. The stock has a fifty day simple moving average of $35.22 and a two-hundred day simple moving average of $38.10. The company has a quick ratio of 0.38, a current ratio of 0.75 and a debt-to-equity ratio of 0.36.
Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last issued its earnings results on Thursday, October 13th. The pharmacy operator reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.77 by $0.03. Walgreens Boots Alliance had a return on equity of 14.39% and a net margin of 3.27%. The business had revenue of $32.45 billion during the quarter, compared to the consensus estimate of $32.17 billion. During the same period last year, the company earned $1.17 EPS. The company’s revenue for the quarter was down 5.3% on a year-over-year basis. As a group, equities analysts forecast that Walgreens Boots Alliance, Inc. will post 4.5 EPS for the current year.
Walgreens Boots Alliance Dividend Announcement
Institutional Trading of Walgreens Boots Alliance
A number of hedge funds and other institutional investors have recently modified their holdings of WBA. State Street Corp increased its position in shares of Walgreens Boots Alliance by 6.2% during the 3rd quarter. State Street Corp now owns 53,374,188 shares of the pharmacy operator’s stock worth $1,675,950,000 after purchasing an additional 3,095,684 shares during the last quarter. BlackRock Inc. increased its position in shares of Walgreens Boots Alliance by 4.9% during the 1st quarter. BlackRock Inc. now owns 57,751,600 shares of the pharmacy operator’s stock worth $2,585,537,000 after purchasing an additional 2,719,081 shares during the last quarter. Federated Hermes Inc. increased its position in shares of Walgreens Boots Alliance by 76.3% during the 1st quarter. Federated Hermes Inc. now owns 5,229,343 shares of the pharmacy operator’s stock worth $234,118,000 after purchasing an additional 2,263,629 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in Walgreens Boots Alliance by 179.9% during the 1st quarter. Renaissance Technologies LLC now owns 1,910,000 shares of the pharmacy operator’s stock valued at $85,511,000 after acquiring an additional 1,227,700 shares during the period. Finally, Marshall Wace LLP purchased a new position in Walgreens Boots Alliance during the 3rd quarter valued at about $38,288,000. 57.33% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
WBA has been the topic of a number of recent analyst reports. Truist Financial increased their target price on Walgreens Boots Alliance from $38.00 to $44.00 in a research report on Tuesday, November 8th. UBS Group decreased their target price on Walgreens Boots Alliance from $40.00 to $37.00 and set a “neutral” rating on the stock in a research report on Friday, October 7th. Royal Bank of Canada reduced their price objective on Walgreens Boots Alliance from $42.00 to $36.00 and set a “sector perform” rating for the company in a research note on Wednesday, October 19th. Deutsche Bank Aktiengesellschaft raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and increased their price objective for the company from $41.00 to $50.00 in a research note on Friday, November 11th. Finally, Credit Suisse Group reduced their price objective on Walgreens Boots Alliance from $43.00 to $42.00 and set a “neutral” rating for the company in a research note on Friday, October 14th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and an average price target of $43.23.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
- Get a free copy of the StockNews.com research report on Walgreens Boots Alliance (WBA)
- Institutional Support for Analog Devices Remains High
- Is the 60/40 Portfolio Mix Still in Vogue?
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Three CBD Stocks to Dominate a Budding Industry
- Microsoft Shares: Is it Time to Back Up the Truck?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.